Close
Close

Spectral Diagnostics (US) Inc. - Endotoxemia

Partner

Not provided

Rare Disease

Endotoxemia

Sponsor

Spectral Diagnostics (US) Inc.

Access Program Information

Open-label, non-controlled study of standard care plus the TORAYMYXIN PMX-20R (PMX cartridge) in subjects who have endotoxemia and septic shock. This is a continued access study subsequent to the EUPHRATES clinical trial NCT01046669.

Contact
Locations

Free Newsletter